Delivery of protein antigens to the immune system by fusion-active virosomes: A comparison with liposomes and ISCOMs

Bioscience Reports

Volumn 22, Issue 2, 2002, Pages 323-338

  Bungener, Laura ^a   Huckriede, Anke ^a   Wilschut, Jan ^a   Daemen, Toos ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Antigen delivery; Antigen processing; Cytotoxic T lymphocytes; Immunization; ISCOM; Liposomes; Vaccination; Virosomes

Indexed keywords

ANTIGEN; ISCOM; LIPID; LIPOSOME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; OVALBUMIN; VIROSOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; CELL ACTIVITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXIC T LYMPHOCYTE; DRUG DELIVERY SYSTEM; HUMORAL IMMUNITY; IMMUNE SYSTEM; IMMUNOSTIMULATION; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; SHORT SURVEY; VACCINATION; VIRUS ENVELOPE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS; CELLS, CULTURED; CYTOSOL; DENDRITIC CELLS; DRUG COMPOUNDING; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNODOMINANT EPITOPES; ISCOMS; LIPOSOMES; LYMPHOCYTE ACTIVATION; MEMBRANE FUSION; MICE; OVALBUMIN; PEPTIDE FRAGMENTS; PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; VIROSOMES;

ANIMALIA;

EID: 0036555140     PISSN: 01448463     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020198908574     Document Type: Short Survey

References (71)

1. Almeida, J. D., Brand, C. M., Edwards, D. C., and Heath, T. D. (1975) Lancet 2:899-901.
2. Alving, C. R. (1995) Ann. NY Acad. Sci. 754:143-152.
3. Alving, C. R., Koulchin, V., Glenn, G. M., and Rao, M. (1995) Immunol. Rev. 145:5-31.
4. Arkema, A., Huckriede, A., Schoen, P., Wilschut, J., and Daemen, T. (2000) Vaccine 18:1327-1333.
5. Banchereau, J. and Steinman, R. M. (1998) Nature 392:245-252.
6. Banchereau, J., Schuler-Thurner, B., Palucka, A. K., and Schuler, G. (2001) Cell 106:271-274.
7. Bhardwaj, N. (2001) Trends Mol. Med. 7:388-394.
8. Bonnett, M. C. et al. (2000) Immunol. Lett. 74:11-25.
9. Bron, R., Ortiz, A., Dijkstra, J., Stegmann, T., and Wilschut, J. (1993) Methods Enzymol. 220:313-331.
10. Bron, R., Ortiz, A., and Wilschut, J. (1994) Biochemistry 33:9110-9117.
11. Bungener, L. et al. (2002) Vaccine 20:2287-2295.
12. Collins, D. S., Findlay, K., and Harding, C. V. (1992) J. Immunol. 148:3336-3341.
13. Conne, P. et al. (1997) Vaccine 15:1675-1679.
14. Dotsika, E., Karagouni, E., Sundquist, B., Morein, B., Morgan, A., and Villacres-Eriksson, M. (1997) Scand. J. Immunol. 45:261-268.
15. Glack, R., Mischler, R., Brantschen, S., Just, M., Althaus, B., and Cryz, S. J. (1992) J. Clin. Invest. 90:2491-2495.
16. Glück, R., Mischler, R., Finkel, B., Que, J. U., Scarpa, B., and Cryz, S. J. (1994) Lancet 344:160-163.
17. Glück, R. and Wegmann, A. (1998) In: Medical Applications of Liposomes, (Lasic, D. D. and Papahadjopoulos, eds.) pp. 75-115.
18. Gregoriadis, G. (1994) J. Drug Target 2:351-356.
19. Grewal, I. S. and Flavell, R. A. (1996) Immunol. Rev. 153:85-106.
20. Gunzer, M., Janich, S., Varga, G., and Grabbe, S. (2001) Semin. Immunol. 13:291-302.
21. Harding, C. V., Collins, D. S., Kanagawa, O., and Unanue, E. R. (1991) J. Immunol. 147:2860-2863.
22. Harding, C. V. (1996a). J. Clin. Immunol. 16:90-96.
23. Harding, C. V. (1996b) Crit. Rev. Immunol. 16:13-29.
24. Hayashi, A. et al. (1999) Biochem. Biophys. Res. Commun. 261:824-828.
25. Heath, W. R. and Carbone, F. R. (1999) Curr. Opin. Immunol. 11:314-318.
26. Heeg, K., Kuon, W., and Wagner, H. (1991) Eur. J. Immunol. 21:1523-1527.
27. Hernandez, L. D., Hoffman, L. R., Wolfsberg, T. G., and White, J. M. (1996) Annu. Rev. Cell Dev. Biol. 12:627-661.
28. Hewson, R. (2000) Mol. Med. Today 6:28-35.
29. Leitner, W. W., Ying, H., and Restifo, N. P. (2000) Vaccine 18:765-777.
30. Loutan, L., Bovier, P., Althaus, B., and Glück, R. (1994) Lancet 343:322-324.
31. Lövgren-Bengtsson, K. and Sjölander, A. (1996) Vaccine 14:753-760.
32. Machy, P., Serre, K., and Leserman, L. (2000) Eur. J. Immunol. 30:848-857.
33. Matlin, K. S., Reggio, H., Helenius, A., and Simons, K. (1981) J. Cell Biol. 91:601-613.
34. Mengiardi, B., Berger, R., Just, M., and Glück, R. (1995) Vaccine 13:1306-1315.
35. Morein, B., Sundquist, B., Höglund, S., Dalsgaard, K., and Osterhaus, A. (1984) Nature 308:457-460.
36. Morein, B., Villacrés-Eriksson, M., Sjölander, A., and Lövgren-Bengtsson, K, (1996) Vet. Immunol. Pathology 54:373-384.
37. Mowat, A. M., Donachie, A. M., Reid, G., and Jarrett, O. (1991) Immunology 72:317-322.
38. Mowat, A. M., Maloy, K. J., and Donachie, A. M. (1993) Immunology 80:527-534.
39. Nair, S., Zhou, F., Reddy, R., Huang, L., and Rouse, B. T. (1992) J. Exp. Med. 175:609-612.
40. Nakanishi, T. et al. (1997) Biochem Biophys. Res. Commun. 240:793-797.
41. Nakanishi, T. et al. (1999) J. Controlled Release 61:233-240.
42. Nakanishi, T. et al. (2000) Eur. J. Immunol. 30:1740-1747.
43. Ramachandra, L., Noss, E., Boom, W. H., and Harding, C. V. (1999) Cell. Microbiol. 1:205-214.
44. Rao, M. and Alving, C. R. (2000) Adv. Drug Del. Rev. 41:171-188.
45. Reddy, R., Zhou, F., Huang, L., Carbone, F., Bevan, M., and Rouse, B. T. (1991) J. Immunol. Methods 141:157-163.
46. Reddy, R., Zhou, F., Nair, S., Huang, L., and Rouse, B. T. (1992) J. Immunol. 148:1585-1589.
47. Rimmelzwaan, G. F. et al. (2001) Vaccine 19:1180-1187.
48. Rock, K. L. (1996) Immunol. Today 17:131-137.
49. Rodriguez, A., Regnault, A., Kleijmeer, M., Riccardi-Castagnoli, P., and Amigorena, S. (1999) Nat. Cell Biol. 1:362-368.
50. Sambhara, S. et al. (1997) Mech. Ageing and Devel. 96:157-169.
51. Sambhara, S. et al. (1998) J. Infect. Dis. 177:1266-1274.
52. Schoen, P., Bron, R., and Wilschut, J. (1993) J. Liposome Res. 3:767-792.
53. Schoen, P., Chonn, A., Cullis, P. R., Wilschut, J., and Scherrer, P. (1999) Gene Ther. 6:823-832.
54. Schultze, J., Nadler, L. M., and Gribben, J. G. (1996) Blood Rev. 10:111-127.
55. Serre, K. et al. (1998) J. Immunol. 161:6059-6067.
56. Shedlock, D. J. and Weber, D. B. (2000) J. Leukoc. Biol. 68:793-806.
57. Sjölander, A., Lövgren-Bengtsson, K., and Morein, B. (1997) Vaccine 15:1033-1038.
58. Sjölander, A. et al. (2001) Vaccine 19:2661-2665.
59. Stegmann, T., Morselt, H. W., Booy, F. P., van Breeman, J. F., Scherphof, G., and Wilschut, J. (1987) EMBO J. 6:2651-2659.
60. Stegmann, T. et al. (1993) Biochemistry 32:11330-11337.
61. Stittelaar, K. J. et al. (2000) Vaccine 18:2482-2493.
62. Takahashi, H., Takeshita, T., Morein, B., Putney, S., Germain, R. N., and Berzofsky, J. A. (1990) Nature 344:873-875.
63. Tarpey, I., Stacey, S. N., McIndoe, A., and Huw Davis, D. (1996) Vaccine 14:230-236.
64. Théry, C. and Amigorena, S. (2001) Curr. Opin. Immunol. 13:45-51.
65. Verschoor, E. J. et al. (1999) J. Virol. 73:3292-3300.
66. Watson, D. L., Watson, N. A., Fossum, C., Lovgren, K., and Morein, B. (1992) Microbiol. Immunol. 36:199-203.
67. Wijburg, O. L. C., van den Dobbelsteen, G. P. J. M., Vadolas, J., Sanders, A., Strugnell, R. A., and van Rooijen, N. (1998) Eur. J. Immunol. 28:479-487.
68. Wilson, A. D., Lövren-Bengtsson, K., Villacres-Eriksson, M., Morein, B., and Morgan, A. J. (1999) Vaccine 17:1282-1290.
69. Yewdell, J. W., Norbury, C. C., and Bennink, J. R. (1999) Adv. Immunol. 73:1-77.
70. Zhou, F., Rouse, B. T., and Huang, L. (1992) Cancer Res. 52:6287-6291.
71. Zhou, F., Watkins, S. C., and Huang, L. (1994) Immunobiol. 190:35-52.